Form 13-F position report

EQUILLIUM INC

Reported by ACADIAN ASSET MANAGEMENT LLC

EQ CUSIP 29446K106 Manager CIK 0000916542

Reported 108,691 shares, unchanged from the prior quarter.

Reported value -70.7%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q2 2024
Shares 108,691 Quarter-end amount reported
Reported value $73,000 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-03-31 249000
2024-06-30 73000
2024-09-30 89000
2024-12-31 80000
2025-03-31 40000
2025-06-30 12000
2025-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

7 quarters
Quarterly reported position history for EQUILLIUM INC held by ACADIAN ASSET MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2025 Reduced 0 -39,475 (-100.0%) 0 $0 2025-11-13
Q2 2025 Reduced 39,475 -69,216 (-63.7%) < 0.01% $12,000 2025-08-07
Q1 2025 Unchanged 108,691 0 (0.0%) < 0.01% $40,000 2025-05-21
Q4 2024 Unchanged 108,691 0 (0.0%) < 0.01% $80,000 2025-02-11
Q3 2024 Unchanged 108,691 0 (0.0%) < 0.01% $89,000 2024-11-12
Q2 2024 Unchanged 108,691 0 (0.0%) < 0.01% $73,000 2024-08-06
Q1 2024 New 108,691 +108,691 (0.0%) < 0.01% $249,000 2024-05-10
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

34 managers reported EQUILLIUM INC for Q2 2024.

Managers reporting EQUILLIUM INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Decheng Capital LLC Unchanged 4,447,308 0 0.94% $3,082,874 3 qtrs
TAKEDA PHARMACEUTICAL CO LTD Unchanged 1,824,977 0 0.54% $1,259,234 3 qtrs
VANGUARD GROUP INC Unchanged 841,948 0 < 0.01% $583,639 23 qtrs
Cota Capital Management LLC Unchanged 562,278 0 1.38% $389,771 10 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 300,400 +91,200 < 0.01% $208,237 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 216,204 +16,476 < 0.01% $149,898 16 qtrs
ADAR1 Capital Management LLC Reduced 140,775 -58,000 0.02% $97,585 3 qtrs
ACADIAN ASSET MANAGEMENT LLC This report Unchanged 108,691 0 < 0.01% $73,000 2 qtrs
Callan Capital LLC Unchanged 99,688 0 < 0.01% $69,104 7 qtrs
STATE STREET CORPORATION Added 59,720 +7,100 < 0.01% $41,398 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 06, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
108,691
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.